| Topic | HORIZON-HLTH-2027-01-DISEASE-10 |
|---|---|
| Status | Forthcoming |
| Call | HORIZON-HLTH-2027-01 — Cluster 1 - Health (Single stage - 2027/1) |
| Destination | Tackling diseases and reducing disease burden (2026-27) |
| Type of action | Research and Innovation Actions · lump sum |
| Opening | 29 October 2026 |
| Deadline | 17 February 2027 |
| Budget | EUR 3 million to EUR 4 million per project · 3 projects expected · EUR 11.8 million in total |
| Part B page limit | 45 pages (standard application form; check your call) |
| Template | Work Programme 2026–2027 application form |
Expected outcomes
Projects may contribute to some of the expected outcomes; say which ones and why. The topic says: “This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to some of the following expected outcomes:”
- EO1 Researchers, healthcare practitioners and providers in low- and middle-income countries (LMICs) and/or those in high-income countries (HICs) serving disadvantaged populations have access to improved insights and evidence on how to equitably promote the early prevention, risk reduction, and timely diagnosis of Non-Communicable Diseases (NCDs) in children and/or young people.
- EO2 Policymakers, public health managers and authorities, parents and their children, and young adults have access to evidence and recommendations for national programmes and policies to improve quality of life in children and/or young people and extend healthy life expectancy.
- EO3 Researchers, clinicians, policymakers, public health managers and authorities have an improved understanding how to effectively adapt and/or scale up interventions for prevention and management of chronic NCDs in children and/or young people at local, regional, and national levels.
- EO4 Communities, parents and their children, young adults, local stakeholders and authorities are fully engaged in implementing and taking up interventions that tackle NCDs in children and/or young people.
Expected impacts named in the destination
The wider, long-term effects the destination seeks. Your outcomes feed them; they are not project deliverables.
- EI1 Disease burden in the EU and worldwide is reduced through effective disease management, including through the development and integration of innovative preventive, diagnostic and therapeutic approaches, digital and other people-centred solutions for healthcare.
- EI2 Premature mortality from non-communicable diseases is reduced by one third (by 2030), mental health and wellbeing are promoted, and the targets of the World Health Organization (WHO) Global Action Plan for the Prevention and Control of non-communicable diseases, are attained, with an immediate impact on the related disease burden (Disability-Adjusted Life Years - DALYs).
- EI3 Healthcare systems benefit from strengthened Research and Innovation expertise, human capacities and know-how for combatting communicable and non-communicable diseases, including through international cooperation.
- EI4 Citizens benefit from reduced (cross-border) health threat of epidemics and AMR pathogens, in the EU and worldwide,,.
- EI5 Patients and citizens are knowledgeable of disease threats, involved and empowered to make and shape decisions for their health, and better adhere to knowledge-based disease management strategies and policies (especially for controlling outbreaks and emergencies).
What evaluators will look for in this topic
Expected outcomes
- Projects may contribute to some of the expected outcomes; say which ones and why.
- For each outcome (EO1 to EO4), name who will use or adopt your results (a specific group, not “industry” or “society”), how they get them, and the indicator that shows the change, with baseline, target and date.
- Use the topic's own words for each outcome, so the evaluator can tick it off.
What the scope asks for
Evaluators check the proposal against these sentences of the scope. Answer each one visibly, in the call's own words.
- “In this regard, proposals focused on implementation research should explore implementation strategies on evidence-based interventions, adaptations of interventions and tailored interventions, or initiatives including (though not limited to) those focussed on one or more of the following:.”
- “In this instance it would be anticipated that proposals should explore implementation strategies using the appropriate hybrid design study incorporating effectiveness and implementation research outcomes.”
- “The proposed implementation research should be focused on one or more evidence-based interventions (or complex interventions), providing existing evidence of the intervention’s effectiveness, cost-effectiveness, sustainability, scalability and potential for long-term health and other impacts (and in what context this evidence has been generated).”
- “Applicants should provide rationale and explore the implementation of proposed intervention(s) for a selected study population(s) based in one or more LMICs, and/or underserved populations experiencing health disparities, including Indigenous populations, in HICs, considering the unique social, political, economic, and cultural context(s) in which the study will take place.”
- “Applicants should justify why any adaptation will not compromise the known effectiveness of the selected intervention(s).”
- “Proposals should address all the following implementation research activities:.”
- “With regard to NCDs, applicants are encouraged to explore any chronic non-communicable condition (or combination of conditions), including mental health disorders, autoimmune conditions, musculoskeletal conditions, neurological disorders and sleep disorders and/or any risk factor (or combination of risk factors).”
- “Proposals should use an appropriate implementation research design and framework, before and after studies, and additional implementation science classifications of study designs (e.g. hybrid designs), noting that applicants are not limited to any particular design.”
- “Proposed work should identify and engage all key stakeholders necessary and relevant to the development, undertaking and knowledge translation phases of the project, including meaningful collaboration with young people themselves (and their families).”
- “Proposals should also consider using co-development and co-design approaches, involving policymakers, local authorities, community groups, educators, healthcare providers, and other individuals or organisations necessary to the delivery and sustainability of the study outcomes.”
- “Project partners should be engaged from the beginning to contribute to the sustainability of the intervention after the end of project.”
- “Proposals should demonstrate sustainability of the strategy, beyond the lifespan of the project.”
Conditions that shape the proposal
- Part B, sections 1–3: 45 pages (standard application form). Text beyond the limit is not read; tables and figures count.
- Lump sum: the budget is fixed per work package and paid when each work package is completed. Every work package needs activities and deliverables an evaluator can verify, and the effort must match the money.
- Other Eligibility Conditions: “In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.”
- Evaluation and award: Submission and evaluation processes: “The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.”
Impact pathway and traps
- Users or citizens are part of the scope. Show how they take part in the design and testing, not only that they are informed.
- The scope expects pilots or demonstration. Name the sites, the partners who run them and what is measured there.
- Keep outputs, outcomes and impacts apart: what you deliver, what changes when others use it, and the long-term effect.
- For each destination impact you claim, show which of your outcomes feeds it. Destination impacts are long-term effects, not project deliverables.
- Name the barriers outside the project (regulation, markets, user behaviour) that could block uptake, and what you will do if they do.
- Section 2.3 (the summary canvas) is optional on this call; the old split into scientific, economic and societal impact is no longer required.
The scope, as published
The Commission is a member of the Global Alliance for Chronic Diseases (GACD). The GACD specifically addresses NCDs and supports implementation research to improve health outcomes. This topic is launched in concertation with the other GACD members (international funding agencies) and aligned with the 12 th GACD call. Chronic NCDs that begin in childhood have an impact on both quality of life and life expectancy. Onset of many NCDs diseases occurs at younger ages in LMICs, and this is further accompanied by a longer duration of disease and a higher rate of complications, including multimorbidity. The conditions in which people are born, grow and live (the social determinants of health) including access to good nutrition, education, housing, and healthcare are major contributors to health and ill health. Up to 70% of preventable adult deaths from NCDs are linked to risk factors originating in childhood and adolescence, and interventions that can successfully control or prevent chronic disease in young people can dramatically improve health outcomes later in life. Childhood and adolescence are critical periods, when behaviours associated with NCD risk are adopted including tobacco use, alcohol use, substance abuse, unhealthy diets and sedentary lifestyles and children and young people are often targeted by commercial marketing of unhealthy products. The aim of this topic is to fund implementation research, exploring strategies, evidence-based program and policy interventions across prevention, diagnosis, screening and management of chronic NCDs, centred on the critical life stages spanning early childhood to young adulthood (1-24 years of age) living in LMICs, and/or underserved populations in HICs. In this regard, proposals focused on implementation research should explore implementation strategies on evidence-based interventions, adaptations of interventions and tailored interventions, or initiatives including (though not limited to) those focussed on one or more of the following: Policy evaluation to tackle childhood- and/or youth-relevant social, economic, political, structural or commercial determinants of chronic NCD conditions. Prevention of NCDs using children and/or young people targeted implementation strategies (e.g. educational strategies, vaccination strategies, promotion of behavioural and lifestyle changes). Screening and diagnosis of NCDs (or risk factors) in children and/or young people (in particular use of digital tools). Cost effective and patient-centred management of NCDs in children and/or young people (including access to medicines and equipment; integrated care pathways; continuity of care for adolescents with existing non-communicable diseases who "age out" of paediatrics, caregiver health and support, citizen science approaches). Multiple interventions focus on prevention of NCDs in children and young people, yet relatively few have focussed on strategies for management of chronic conditions in these critical life stages, and a limited number of studies have been carried out to study implementation of these in LMIC contexts or with underserved communities. In this instance it would be anticipated that proposals should explore implementation strategies using the appropriate hybrid design study incorporating effectiveness and implementation research outcomes. Therefore, it may be important to undertake formative research as a part of the proposal to support readiness for implementation. The proposed implementation research should be focused on one or more evidence-based interventions (or complex interventions), providing existing evidence of the intervention’s effectiveness, cost-effectiveness, sustainability, scalability and potential for long-term health and other impacts (and in what context this evidence has been generated). Applicants should provide rationale and explore the implementation of proposed intervention(s) for a selected study population(s) based in one or more LMICs, and/or underserved populations experiencing health disparities, including Indigenous populations, in HICs, considering the unique social, political, economic, and cultural context(s) in which the study will take place. Applicants should justify why any adaptation will not compromise the known effectiveness of the selected intervention(s). Proposals should address all the following implementation research activities: Clearly describe the implementation research methodology, including the statistical design. Have an appropriate strategy for measuring implementation research outcomes and real-world effectiveness outcomes and indicators. Specifically address issues of equitable implementation to ensure interventions reach the populations that need them the most. Engage an appropriately expert and skilled research team which can ensure a suitable multidisciplinary approach and that demonstrates equitable partnership and shared leadership between HIC-LMIC, and/or non-Indigenous-Indigenous members of the project team and external stakeholders through a clear governance strategy. Provide a stakeholder engagement strategy with evidence of support/engagement from key stakeholders for delivering the intervention and a pathway to sustain the proposed intervention (if proven effective) after the funding from the GACD grant ends. Provide opportunities for NCD-focused implementation research capacity building for early career researchers and team members from lower resourced environments, such as LMICs or disadvantaged communities. Ensure meaningful involvement of early career team members, including at least one early career member as a co-investigator. The study population may include children and/or young people in the general population, with one or more existing NCDs, those currently without NCDs, or a combination of any of the above. Applicants may propose implementation research focused on interventions that are implemented at the individual, family, community (e.g. work or school),…
Other topics in HORIZON-HLTH-2027-01
- HORIZON-HLTH-2027-01-CARE-02 — Personalised approaches to reduce risks from Adverse Drug Reactions due to…
- HORIZON-HLTH-2027-01-DISEASE-05 — Development of novel small molecule antiviral therapeutics for pathogens with…
- HORIZON-HLTH-2027-01-DISEASE-06 — Development of monoclonal antibodies to prevent and treat infections from…
- HORIZON-HLTH-2027-01-DISEASE-07 — Development of monoclonal antibodies to prevent and treat infections from…
- HORIZON-HLTH-2027-01-DISEASE-08 — Development of innovative antimicrobials against pathogens resistant to…
- HORIZON-HLTH-2027-01-ENVHLTH-02 — Integrating climate-related exposures into the human exposome and…
- HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 — Tools and technologies to support health adaptation to climate change
- HORIZON-HLTH-2027-01-IND-01 — Development of cell-free protein synthesis platforms for discovery and/or…
- HORIZON-HLTH-2027-01-STAYHLTH-01 — Addressing disabilities through the life course to support independent living…
Source and attribution
Topic text from the official topic page on the EU Funding & Tenders Portal, retrieved 19 October 2026. © European Union, reused under Commission Decision 2011/833/EU (CC BY 4.0). Changes: the expected outcomes and impacts are split into numbered statements, long passages are shortened, and the evaluator checklist is GrantWise's own commentary. Your call and the Work Programme always win; check them before you submit. GrantWise is independent and not affiliated with, endorsed by, or acting on behalf of the European Commission.